About nference
nference is a Healthcare company based in Cambridge (United States) founded in 2013 by Venky Soundararajan and Murali Aravamudan. AI platform provided for clinical data analysis and insights. nference has raised $193.74 million across 5 funding rounds from investors including Mayo Clinic, Matrix and Mayo Clinic Ventures. The company has 362 employees. nference has completed 2 acquisitions, including Predible and Spectral Insights. Its chief executive, as recorded, is Murali Aravamudan. Its Indian entity Nference Labs Private Limited reported revenue of ₹155 Cr. nference offers products and services including Real World Evidence Platform, Data De-identification Algorithms, Data Quality Validation Framework, and Proprietary Knowledge Graph. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics. Its competitors include Elation Health, AdvancedMD and Flywheel; 2 of its 3 listed competitors have raised funding.
Company details
nference was founded in 2013 and is headquartered in Cambridge, United States. An AI platform is offered for analyzing clinical data and generating insights within the healthcare sector. Patient cohorts are designed, patient journeys are explored, and data is annotated to support model development. An advanced data science workbench is included, with capabilities for anatomical computations. Patient privacy is maintained throughout operations.
- Headquarters Cambridge, United States
- Employees 362
- Founders Venky Soundararajan, Murali Aravamudan
- SectorsHealthcare
- Email••••••••
- Website nference.com
- Social LinkedIn X
- Legal Name Nference Labs Private Limited
- Date of Incorporation 22 May, 2018
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹155 Cr
FY 2025 · -13% YoY
- Indian entity net profit₹16.26 Cr
FY 2025 · 11% margin
- Indian entity EBITDA₹23.65 Cr
FY 2025 · 15% margin
- Total Equity Funding$193.74M (USD)
in 5 rounds
- Latest Funding Round$2.74M (USD), Series C
Nov 2022
- InvestorsMayo Clinic
& 3 more
- Employee Count362
- Investments & AcquisitionsPredible
& 1 more
Associated legal entities of nference
nference operates through Nference Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nference Labs Private Limited CIN U72900KA2018FTC113334 | Active | 22 May 2018 | Bangalore, Karnataka | ₹155 Cr | 362 | 3 | View details |
Products & Services of nference
nference offers a comprehensive portfolio of products and services, including Real World Evidence Platform, Data De-identification Algorithms, Data Quality Validation Framework, and Proprietary Knowledge Graph.
Platform for analyzing healthcare data to enhance research and treatments.
Tools to anonymize structured and unstructured healthcare data securely.
Framework for validating and curating clinical data for analysis.
System to harmonize patient data into organized variables for insights.
Funding Insights of nference
nference has successfully raised a total of $193.74M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $2.74 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $193.74M
- Total Rounds 5
- Last Round Series C — $2.74M
- First Round $11M
(Jun 2018)
- Investors Count 4
All 5 funding rounds of nference with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2022 | $2.74M | Series C | – | – | – |
| Dec 2020 | $60M | Series C | – | Matrix | |
| Jan 2020 | $60M | Series B | – | Mayo Clinic, Mayo Clinic Ventures | |
| Jan 2020 | $60M | Series B | – | – | |
| Jun 2018 | $11M | Series A | – | – |
4 investors in total: 4 institutional.
Investors in nference
nference has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Mayo Clinic, Matrix and Mayo Clinic Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage ventures are funded by the investment firm. | matrix.vc | San Francisco, United States | ||
Venture capital investments are provided to innovative startups by NTTVC. | nttvc.com | |||
| ventures.mayoclinic.org | ||||
General medical clinics are operated throughout the United States. | 1864 | mayoclinic.org | United States |
Investor details for nference
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Nference Labs Private Limited (nference)
Nference Labs Private Limited is the primary company behind nference. The board of Nference Labs Private Limited currently have 3 directors; the longest-serving is Murali Aravamudan, appointed in 2018. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Murali Aravamudan DIN 00319652 | Director | 22 May 2018 | 8 yrs 5 mo | Nference Labs Private Limited |
| Viswanathan Thiagarajan DIN 08139680 | Director | 22 May 2018 | 8 yrs 5 mo | Nference Labs Private Limited |
| S Venkataramanan DIN 08142443 | Director | 24 May 2018 | 8 yrs 5 mo | Nference Labs Private Limited |
People of nference
110 people are tracked at nference (35 in leadership, 2 in board & advisors, 73 in team); the tracked headcount is 362.
| Name | Role | Group |
|---|---|---|
Venky Soundararajan | Co-Founder | Leadership |
| Co-Founder & CEO | Leadership | |
Wui Ip | Medical Director Of Healthcare Data | Leadership |
Arjun Puranik | Head Of Math & Statistics | Leadership |
Ashim Prasad | Sr. Director - Data Science | Leadership |
Hutch Fishman | Cfo/ Treasurer | Leadership |
Ajit Rajasekharan | CTO | Leadership |
Anita Kawatra | Chief Corporate Affairs Officer | Leadership |
Vineet Agarwal | Senior Director Data | Leadership |
Shashi Kant | Associate Director-data Science | Leadership |
Manish Kumar | Director, Cloud Engineering | Leadership |
Prasanth Perugapalli | Chief Product Officer, Pramana | Leadership |
Maulik Nanavaty | President, Ventures | Leadership |
Sreedhar Perim | Associate Director Of Engineering | Leadership |
Tim Demakis | Senior Vice President Finance | Leadership |
Aj Venkatakrishnan | Vice President, Scientific Research | Leadership |
John Monahan | Head Of Clinical Strategy | Leadership |
Santhosh Kumar.n | Senior Director, Global Head Of Information Technology & Security | Leadership |
Jonathan Bell | Director Of Strategic Partnerships | Leadership |
Trisha Ellis | Chief People Officer | Leadership |
90 more people are available in the full profile.
Complete people profiles for nference
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of nference
Figures of Nference Labs Private Limited, the primary company behind nference, for FY 2025. Revenue was ₹155 Cr (-13% year on year). Net profit was ₹16.26 Cr (11% margin). EBITDA was ₹23.65 Cr (15% margin). Revenue has grown at a compounded annual rate of +21% over three years and +48% over five years.
- ₹155 CrRevenue · FY 2025 · -13% YoY
- ₹16.26 CrNet profit · 11% margin
- ₹23.65 CrEBITDA · 15% margin
- ₹1 LakhPaid-up capital
- 362Employees (provident fund records)
- +21%Revenue CAGR, 3 years
- +48%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Nference Labs Private Limited are on its company page.
Detailed financial statements for nference
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by nference
nference has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Predible and Spectral Insights.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
AI-based radiological analysis is provided for lung disease diagnosis. | predible.com | Bengaluru, India | 2016 | May 2022 | •••• | |
Developer of hyperspectral medical imaging solutions | spectralinsights.com | Bengaluru, India | 2016 | Jun 2020 | •••• |
Complete acquisition details for nference
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of nference
5 dated milestones of nference across 9 years, from founding to its latest funding, stage changes and deals.
- Founded nference is founded.
- Funding First funding round of $11.0M.
- Acquisition Acquires Spectral Insights.
- Acquisition Acquires Predible.
- Funding Latest funding round, Series C, of $2.7M.
Competitors of nference
nference has 3 listed competitors in our database, 2 of them funded. They include Elation Health, AdvancedMD and Flywheel.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| elationhealth.com | 2010 | San Francisco, United States | $90M | 156 | Online EHR is offered for private practice physicians' patient-centered care. | |
| advancedmd.com | 1999 | South Jordan, United States | 654 | Cloud-based practice management, electronic health record (EHR), and medical scheduling software | ||
| flywheel.io | 2015 | Minneapolis, United States | $123.86M | Cloud-based platform for healthcare data capture and analysis is offered. |
Detailed competitors of nference
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of nference
The website of nference (nference.com) receives about 8.3K visits a month.
- Monthly visits8.3K
▲ 28.8% vs previous month
Websites whose visitors overlap most with nference. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| amsterdamumc.org | 100% | 254.9K | #235,407 | View details |
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as nference (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nference
Complete news archive for nference
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about nference
nference was founded in 2013 and raised its 1st funding round 5 years after it was founded.
nference is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Murali Aravamudan is the CEO of nference, as recorded in our data. They have also founded this company.
nference is a funded company, having raised a total of $193.74M across 5 funding rounds to date. The company's 1st funding round was a Series A of $11M, raised on Jun 2018.
nference has 362 employees.
The primary company behind nference, Nference Labs Private Limited, reported revenue of ₹155 Cr for FY 2025, down 13% year on year.
nference was founded in 2013 and is headquartered in Cambridge, United States. An AI platform is offered for analyzing clinical data and generating insights within the healthcare sector. Patient cohorts are designed, patient journeys are explored, and data is annotated to support model development. An advanced data science workbench is included, with capabilities for anatomical computations. Patient privacy is maintained throughout operations.
nference's top competitors include Elation Health, AdvancedMD and Flywheel.
nference offers Real World Evidence Platform, Data De-identification Algorithms, Data Quality Validation Framework, and Proprietary Knowledge Graph.
nference has made 2 acquisitions, including Predible, and Spectral Insights.
nference has 4 investors. Key investors include Mayo Clinic, Matrix, Mayo Clinic Ventures, and NTTVC.
nference operates through Nference Labs Private Limited.